Key facts
- BRIJ Medical’s last known valuation is $11.6M (Feb 2024).
- It has raised $12.6M across 2 recorded rounds; the latest was Seed Round ($1.2M) in Feb 2025.
- Notable investors include MedTech Innovator, Biolocity, Georgia Research Alliance, Tim Gleeson, Timothy Gleeson.
- BRIJ Medical has filed 2 Form Ds with the SEC since 2024, most recently Mar 2025 ($1.2M sold to 17 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for BRIJ Medical
Funding rounds
2 roundsAbout BRIJ Medical
Developer of a force-modulating tissue bridge system designed to relieve tension and heal tissues during post-wound closure. The company's device adheres to the skin for extended periods using medical-grade adhesive, eliminating the need for sutures or staples while allowing uninterrupted healing for reducing scar appearance, enabling healthcare providers to improve surgical outcomes and patient satisfaction.
- Sector
- Healthcare
- HQ
- Marietta, GA, United States
- Founded
- 2016
- Employees
- 38
- Website
- brijmedical.com/
- Ownership
- Privately Held (backing)
BRIJ Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BRIJ Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BRIJ Medical in its N-PORT filings yet. We sweep new filings monthly.